Krystal Biotech (KRYS) News Today $143.01 +1.66 (+1.17%) Closing price 07/3/2025 03:17 PM EasternExtended Trading$146.50 +3.49 (+2.44%) As of 07/3/2025 04:45 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Why Is Krystal Biotech Up Today?Toggle Visibility of Why Is Krystal Biotech Up Today?Krystal Biotech, Inc. (NASDAQ:KRYS) News Summary Positive Sentiment: Clear Street initiated coverage of KRYS with a Buy recommendation, reflecting growing institutional confidence. Clear Street Initiates Coverage of Krystal Biotech (KRYS) with Buy Recommendation Positive Sentiment: A Yahoo Finance analysis highlights that KRYS’s fundamentals remain strong and suggests the stock may be undervalued by the broader market. Krystal Biotech, Inc.'s (NASDAQ:KRYS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? Neutral Sentiment: Barron's published an updated research & ratings overview for KRYS, compiling the latest analyst opinions and price targets. Krystal Biotech Inc. Research & Ratings | KRYS - Barron's Neutral Sentiment: A Benzinga report dives into KRYS’s recent short interest, offering data that may help gauge investor sentiment and potential upside from a short squeeze. Peering Into Krystal Biotech's Recent Short Interest Negative Sentiment: HC Wainwright lowered its FY2026 EPS estimate for KRYS to $6.07 from $6.30, signaling a more conservative outlook on long-term profitability. FY2026 EPS Estimates for Krystal Biotech Reduced by Analyst Negative Sentiment: The same firm trimmed its Q2 2025 EPS forecast to $1.26 from $1.71, pointing to potential near-term revenue headwinds despite maintaining a Buy rating and $240 target. Krystal Biotech Q2 EPS Estimate Lowered by HC Wainwright Posted 5h agoAI Generated. May Contain Errors. KRYS Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Analysts Offer Predictions for Krystal Biotech Q2 Earnings3 hours ago | americanbankingnews.comKrystal Biotech Inc. Research & Ratings | KRYS - Barron'sJuly 3 at 4:10 PM | barrons.comFY2026 EPS Estimates for Krystal Biotech Reduced by AnalystJuly 3 at 2:59 AM | americanbankingnews.comKrystal Biotech, Inc.'s (NASDAQ:KRYS) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?July 3 at 2:42 AM | finance.yahoo.comClear Street Initiates Coverage of Krystal Biotech (KRYS) with Buy RecommendationJuly 3 at 2:42 AM | msn.comPeering Into Krystal Biotech's Recent Short InterestJuly 3 at 2:42 AM | benzinga.comKrystal Biotech Q2 EPS Estimate Lowered by HC WainwrightJuly 2 at 7:41 AM | marketbeat.comDino A Rossi Exhibits Confidence With An Acquisition Of Krystal Biotech Stock Options Worth $6KJuly 1 at 12:02 PM | benzinga.comInsider Decision Unfolding At Krystal Biotech: Christopher Mason Exercises Options, Resulting In $0July 1 at 12:02 PM | benzinga.comHC Wainwright Reduces Earnings Estimates for Krystal BiotechJuly 1 at 8:00 AM | marketbeat.comLisanti Capital Growth LLC Acquires Shares of 30,410 Krystal Biotech, Inc. (NASDAQ:KRYS)June 29, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Receives $211.13 Consensus Target Price from BrokeragesJune 28, 2025 | americanbankingnews.comStrength Seen in Krystal Biotech (KRYS): Can Its 4.2% Jump Turn into More Strength? - NasdaqJune 27, 2025 | nasdaq.comKrystal Biotech, Inc.: Krystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with ...June 26, 2025 | finanznachrichten.deWealthquest Corp Makes New $347,000 Investment in Krystal Biotech, Inc. (NASDAQ:KRYS)June 25, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Receives Average Rating of "Buy" from AnalystsJune 25, 2025 | marketbeat.comKrystal Biotech Inc News (KRYS) - Investing.comJune 24, 2025 | investing.comKrystal Biotech's (KRYS) "Buy" Rating Reiterated at HC WainwrightJune 24, 2025 | marketbeat.comKrystal Biotech, Inc. Doses First Patient in Phase 3 Trial Evaluating KB803 for Corneal Abrasion Treatment in Dystrophic Epidermolysis Bullosa PatientsJune 24, 2025 | quiverquant.comQKrystal Biotech Announces First Patient Dosed in Phase 3 Clinical Trial of KB803 for the Treatment and Prevention of Corneal Abrasions in Patients with Dystrophic Epidermolysis BullosaJune 24, 2025 | globenewswire.comJanney Montgomery Scott LLC Has $8.28 Million Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)June 21, 2025 | marketbeat.com2KRYS : $100 Invested In This Stock 5 Years Ago Would Be Worth This Much TodayJune 20, 2025 | benzinga.comRoman Butler Fullerton & Co. Buys New Shares in Krystal Biotech, Inc. (NASDAQ:KRYS)June 18, 2025 | marketbeat.comIs Abeona Therapeutics' Zevaskyn Worth $3.1m Per Treatment, Or Will Krystal Biotech Remain The Market Leader?June 16, 2025 | seekingalpha.comHandelsbanken Fonder AB Sells 11,000 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)June 12, 2025 | marketbeat.comBrokers Offer Predictions for Krystal Biotech FY2026 EarningsJune 10, 2025 | marketbeat.comHennion & Walsh Asset Management Inc. Sells 3,473 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)June 6, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Shares Purchased by GAMMA Investing LLCJune 6, 2025 | marketbeat.comKrystal Biotech to Present at Goldman Sachs 46th Annual Global Healthcare ConferenceJune 3, 2025 | finance.yahoo.comImplied Volatility Surging for Krystal Biotech Stock OptionsJune 2, 2025 | msn.comUniversal Beteiligungs und Servicegesellschaft mbH Acquires Shares of 23,197 Krystal Biotech, Inc. (NASDAQ:KRYS)June 2, 2025 | marketbeat.comSquarepoint Ops LLC Has $1.50 Million Stock Position in Krystal Biotech, Inc. (NASDAQ:KRYS)June 1, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Given Average Rating of "Buy" by BrokeragesJune 1, 2025 | marketbeat.comKrystal Biotech Enters Oversold Territory (KRYS)May 30, 2025 | nasdaq.comKrystal Biotech (NASDAQ:KRYS) Hits New 12-Month Low - Here's WhyMay 28, 2025 | marketbeat.comUBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Sells 14,743 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)May 28, 2025 | marketbeat.comBank of America Corp DE Has $11.88 Million Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)May 25, 2025 | marketbeat.comPalisades Investment Partners LLC Purchases 3,436 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)May 24, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) is Frazier Life Sciences Management L.P.'s 4th Largest PositionMay 23, 2025 | marketbeat.comWoodline Partners LP Buys 41,287 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)May 23, 2025 | marketbeat.comNuveen Asset Management LLC Has $47.64 Million Stake in Krystal Biotech, Inc. (NASDAQ:KRYS)May 22, 2025 | marketbeat.comDeutsche Bank AG Has $3.97 Million Stock Holdings in Krystal Biotech, Inc. (NASDAQ:KRYS)May 22, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Position Cut by BNP Paribas Financial MarketsMay 22, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) is Soleus Capital Management L.P.'s 5th Largest PositionMay 21, 2025 | marketbeat.comRafferty Asset Management LLC Sells 18,639 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)May 21, 2025 | marketbeat.comAmeriprise Financial Inc. Acquires 23,727 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS)May 19, 2025 | marketbeat.comKrystal Biotech, Inc. (NASDAQ:KRYS) Stock Position Reduced by Nicholas Investment Partners LPMay 17, 2025 | marketbeat.comThe Analyst Verdict: Krystal Biotech In The Eyes Of 12 ExpertsMay 17, 2025 | benzinga.comPharma Fire Sale: 3 Stocks the RSI Says You Shouldn't IgnoreMay 14, 2025 | msn.comPharma Fire Sale: 3 Stocks the RSI Says You Shouldn’t Ignore (KRYS)These 3 pharma stocks have oversold RSIs and solid analyst support, setting up potential bounce-back trades through this week and next...May 14, 2025 | marketbeat.com Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address KRYS Media Mentions By Week KRYS Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. KRYS News Sentiment▼0.170.54▲Average Medical News Sentiment KRYS News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. KRYS Articles This Week▼197▲KRYS Articles Average Week Get Krystal Biotech News Delivered to You Automatically Sign up to receive the latest news and ratings for KRYS and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies SMMT News ITCI News GMAB News RDY News QGEN News VTRS News ASND News MRNA News BBIO News BPMC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:KRYS) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredElon just did WHAT!?As you may recall, Biden and the Fed were working on a central bank digital currency, or CBDC. Had they got...Brownstone Research | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… and it's all thanks to President Trump. His administr...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Krystal Biotech, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Krystal Biotech With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free KRYS Stock Alerts